Blood Transcriptome Data For Kidney Transplant Rejection Biomarker Analysis

A 2026 analysis re-evaluates transcriptome data from kidney transplant recipients with and without biopsy-proven rejection. The study compares five pre-filtering methods and eight multivariate classification techniques to derive robust gene expression classifiers. Authored by Oliver P. Günther, this work focuses on identifying biomarkers for transplant rejection.

Use Cases

• Compare classifier performance (e.g., PAM, XGBoost) on filtered gene sets (71 to 800 genes) for predicting biopsy-proven rejection.
• Analyze functional pathways like neutrophil degranulation and interleukin signaling using differentially expressed gene lists from rejection cases.
• Benchmark pre-filtering strategies for feature selection in transcriptome data to mitigate over-fitting in predictive models.

Strengths

• Analyzes transcriptome data from a case-control study of kidney transplant recipients with biopsy-proven rejection.
• Compares performance of 40 distinct analytical combinations (5 pre-filtering methods x 8 classification methods).
• Identifies specific gene panels ranging from 71 to 800 differentially expressed genes for biomarker refinement.

Limitations

• The underlying sample size (number of patient records) for the transcriptome data is not specified.
• The dataset is presented as a 10.7 MB PDF supplementary file, limiting direct computational analysis of raw data.
• Temporal coverage and geographic origin of the patient cohort are not detailed.

Provenance

Source

Oliver P. Günther via figshare.

Collection Method

Re-analysis of previously published transcriptome data using a case-control design and multiple partition nested cross-validation.

Freshness

Last updated in April 2026.